25-Jan-2007 - Vetter Pharma International GmbH

Vetter gains approval for new production plant

Vetter Pharma-Fertigung GmbH & Co. KG has received a manufacturing license in accordance with the German Drug Law from the Tuebingen Regional Board for its new state-of-the-art plant Ravensburg Vetter South. After a planning and construction period of only three years and an investment of 100 Million euros, one of the world's most modern production facilities is now ready to begin work.

According to the company, Vetter can offer products of the highest quality, thanks to the highest possible level of automation and an ultra-modern Restricted Access Barrier System. In addition to dual-chamber syringes and cartridges, the new location will enable the company to also fill liquid or lyophilized vials, as well as single-chamber cartridges.

Facts, background information, dossiers
More about Vetter